L. C. Saunders

M&B 28,767: a potent anti-secretory and anti-ulcer PG analogue. A comparative study with 16, 16' dimethyl PGE2 methylester.

A. K. Banerjee, K. Crowshaw, D. Wyatt, 1984, Life sciences.

Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls

Paul J. Harrison, Gary F. Simons, A. L. Tan, 2023, The Lancet Regional Health - Europe.

Synthesis and anti-ulcer activity of 16-phenoxy analogues of (+)-11-deoxyprostaglandin E1.

A. K. Banerjee, C. Hardy, M. Caton, 1981, Prostaglandins.

Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study

Paul J. Harrison, Gary F. Simons, A. L. Tan, 2023, The Lancet Respiratory Medicine.

Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study

Paul J. Harrison, Jennifer M. Brown, Gary F. Simons, 2022, The Lancet. Respiratory medicine.

SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

Panteleimon G. Takis, Jordan J. Clark, Michael J. Murphy, 2022, eBioMedicine.

Accelerated immune ageing is associated with COVID-19 disease severity

M. G. Jones, M. Halling-Brown, K. Motohashi, 2024, Immunity & Ageing.